Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Woodcock (Manchester (Greater Manchester), United Kingdom). Inhaled therapies: can they breathe new life into asthma?. International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?

Member's Comments

No comment yet.

Related content which might interest you: Inhaled beta2-agonists in asthma management: an evolving story Source: Breathe 2016; 12: 375-377 Year: 2016 Inhaled beta2-agonists and death for asthma: can we overcome this risk? Source: Annual Congress 2007 - Effect of long acting beta-agonists on severe asthma exacerbations and asthma-related deaths Year: 2007 Inhaled corticosteroids in COPD: friend or foe? Source: Eur Respir J, 52 (6) 1801219; 10.1183/13993003.01219-2018 Year: 2018 Inhaled corticosteroids in preschool asthmatics: are they effective and who benefits most? Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003 Long-acting bronchodilators in COPD: where are we now and where are we going? Source: Breathe 2014; 10:110-120 Year: 2014 Is there a problem with inhaled corticosteroid use in COPD? Source: Virtual Congress 2020 – Airway diseases Year: 2020 Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience Source: ERJ Open Res, 8 (1) 00014-2022; 10.1183/23120541.00014-2022 Year: 2022 Optimising bronchodilator therapy in COPD: Who, why and when? Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care Year: 2019 What to use INSTEAD of inhaled corticosteroids in COPD? Source: Eur Respir J 2014; 44: 1391-1393 Year: 2014 Inhaled corticosteroids in treatment of patients with intermittent bronchial asthma: yes or no? Source: Eur Respir J 2005; 26: Suppl. 49, 503s Year: 2005 Is there room for further innovation in inhaled therapy for airways disease? Source: Breathe, 14 (3) 216; 10.1183/20734735.020318 Year: 2018 Inhaled antibiotics: a new tool? Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009 Inhaled medication: which device for which patient? Source: Eur Respir Monogr 2015; 69: 213-223 Year: 2015 Steroids in COPD: still up in the air? Source: Eur Respir J 2010; 35: 949-951 Year: 2010 Poor adherence to inhaled corticosteroids in childhood asthma: Don‘t blame (only) the patient Source: Annual Congress 2011 - Treating childhood asthma Year: 2011 Is it time to move away from short-acting beta-agonists in asthma management? Source: Eur Respir J, 53 (4) 1802223; 10.1183/13993003.02223-2018 Year: 2019 Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013 The secret life of steroids in asthma Source: Eur Respir J 2008; 32: 1135-1137 Year: 2008 Children with mild asthma: do they benefit from inhaled corticosteroids? Source: Eur Respir J 2002; 20: 1470-1475 Year: 2002